Lyra Therapeutics (LYRA) P/E (2020 - 2026)
Lyra Therapeutics (LYRA) P/E from May 1, 2020 to Jul 21, 2026. The TTM Lyra Therapeutics (LYRA) P/E is -0.03. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Lyra Therapeutics (LYRA)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.03 | -83.12% |
| 2025 | -0.17 | +16.41% |
| 2024 | -0.14 | -95.65% |
| 2023 | -3.26 | +178.62% |
| 2022 | -1.17 | -23.61% |
| 2021 | -1.53 | -76.46% |
| 2020 | -6.51 | N/A |
Comparison Lyra Therapeutics (LYRA) P/E with competitors
Lyra Therapeutics (LYRA) P/E is -0.03.